Analytical Data
-
Gene name
SDC1
- Application
-
Alternative Names
SDC1;SDC;Syndecan-1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P18827
-
Expression Region
23-254aa
-
AA Sequence
QIVATNLPPEDQDGSGDDSDNFSGSGAGALQDITLSQQTPSTWKDTQLLTAIPTSPEPTGLEATAASTSTLPAGEGPKEGEAVVLPEVEPGLTAREQEATPRPRETTQLPTTHLASTTTATTAQEPATSHPHRDMQPGHHETSTPAGPSQADLHTPHTEDGGPSATERAAEDGASSQLPAAEGSGEQDFTFETSGENTAVVAVEPDRRNQSPVDQGATGASQGLLDRKEVLG
-
Molecular Weight
39.9kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SDC1, or Syndecan-1, is a heparan sulfate proteoglycan that plays a critical role in cell proliferation, adhesion, migration, and wound healing. It is primarily expressed in epithelial cells and is involved in various physiological and pathological processes, including immunological responses and tumorigenesis. Research into SDC1 has gained traction due to its potential as a biomarker for cancer prognosis and its involvement in the tumor microenvironment. Elevated levels of SDC1 have been associated with aggressive cancer phenotypes and poor patient outcomes, making it a target for therapeutic strategies. Additionally, SDC1 is known to interact with extracellular matrix components and growth factors, influencing cellular signaling pathways that govern tumor development and progression. Studies focus on elucidating the molecular mechanisms by which SDC1 modulates these processes and assessing its utility in clinical settings, particularly for early cancer detection and targeted treatments. Advances in recombinant protein technology have facilitated the production and characterization of SDC1, enabling researchers to explore its structure-function relationship and potential for therapeutic interventions. Overall, the exploration of SDC1 in the context of cancer biology holds promise for enhancing our understanding of tumor dynamics and improving patient management strategies.
